Ciraparantag Completed Phase 2 Trials for Healthy Volunteers (HV) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03288454Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT
NCT03172910Phase 2 Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCT